Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. Now, by reducing the dose in a carefully calculated fashion, clinician researchers have been able to greatly reduce the numbers of patients suffering hearing loss, without compromising effectiveness against tuberculosis.
from Top Health News – ScienceDaily http://bit.ly/2jaTWna
from Tumblr http://bit.ly/2ibtMCg
No comments:
Post a Comment